Efficacy and Safety of Sacral Neuromodulation on Patients With Multiple Sclerosis and Lower Urinary Tract Dysfunction: A Systematic Review and Meta‐Analysis
Neurourology and Urodynamics · 2026
DOI: 10.1002/nau.70163 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Neurourology and Urodynamics, 2026. Verfasst von Carlos Ferreira und 8 weiteren Autor:innen. Beteiligte Einrichtung: Serviço de Urologia, Centro Hospitalar Universitário de São João, Porto, Portugal. Hauptthemen laut MEDLINE: Electric Stimulation Therapy, Lower Urinary Tract Symptoms, Lumbosacral Plexus, Multiple Sclerosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Aim
Treating multiple sclerosis (MS)‐related adult neurogenic lower urinary tract dysfunction (ANLUTD) is challenging because conservative treatments are often ineffective. Sacral neuromodulation (SNM) is a promising minimally invasive treatment of ANLUTD. This review assesses the efficacy and safety of SNM for MS‐related ANLUTD.
Methods
Studies were identified through electronic searches of PubMed and Scopus from inception to August 9, 2024, supplemented by backward and forward manual searches. All studies included were original articles investigating the impact of SNM on urinary symptoms in patients with MS and ANLUTD. Three independent reviewers assessed the quality of evidence using the Oxford Centre for Evidence‐Based Medicine criteria and the ROBINS‐I tool.
Results
Seventeen studies involving 192 patients with MS undergoing SNM were included. The analysis revealed overall success rates of 80% (95% CI, 76%–91%) and 74% (95% CI, 62%–86%) for the test phase (stage I) and permanent SNM (stage II), respectively. Subgroup analyses explored limitations and potential sources of heterogeneity, including gender and type of urinary dysfunction, offering deeper insight into the effectiveness of SNM. With respect to safety, the pooled incidence of complications was approximately 7%, the majority of which were minor and manageable.
Conclusions
This systematic review highlights the potential of SNM to improve urinary symptoms in patients with MS‐related ANLUTD, although the quality of evidence remains low. Further adequately powered randomized clinical trials are needed to clarify long‐term efficacy and safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Serviço de Urologia, Centro Hospitalar Universitário de São João, Porto, Portugal.
- Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
- EPIUnit ITR, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal.
- Serviço de Neurologia, Centro Hospitalar Universitário de São João, Porto, Portugal.
ORCID-Profile: Francisco Cruz
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Ferreira, C., Soeiro, P., Fonseca, S., Arakelyan, Z., Silva, J., Silva, C. M., Cruz, F., Guimarães, J., & Lopes, T. A. (2026). Efficacy and Safety of Sacral Neuromodulation on Patients With Multiple Sclerosis and Lower Urinary Tract Dysfunction: A Systematic Review and Meta‐Analysis. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70163
Vancouver
Ferreira C, Soeiro P, Fonseca S, Arakelyan Z, Silva J, Silva CM, et al. Efficacy and Safety of Sacral Neuromodulation on Patients With Multiple Sclerosis and Lower Urinary Tract Dysfunction: A Systematic Review and Meta‐Analysis. Neurourology and Urodynamics. 2026. doi:10.1002/nau.70163
BibTeX
@article{Ferreira2026,
author = {Ferreira, Carlos and Soeiro, Paula and Fonseca, Sara and Arakelyan, Zaruhi and Silva, João and Silva, Carlos Martins and Cruz, Francisco and Guimarães, Joana and Lopes, Tiago Antunes},
title = {Efficacy and Safety of Sacral Neuromodulation on Patients With Multiple Sclerosis and Lower Urinary Tract Dysfunction: A Systematic Review and Meta‐Analysis},
journal = {Neurourology and Urodynamics},
year = {2026},
doi = {10.1002/nau.70163}
}
EUVIMED